Glomerulonephritis
📧 Sign up to get email alerts when something new happens for Glomerulonephritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria [NA]
This clinical trial update describes efforts to optimize referral pathways for patients with hematuria and moderate-to-severe proteinuria, w…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: The Clinical Application of Artificial Intelligence Assisted Renal Biopsy Diagnosis System.
This update describes an ongoing clinical trial evaluating an AI-assisted renal biopsy diagnosis system. The study targets patients with chr…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous Nephropathy [Phase 2]
A Phase 2 clinical trial is planned to evaluate dapagliflozin for regulating immunological activity in membranous nephropathy; the study is …
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy. [Phase 4]
Clinical trial update for a multicenter Phase 4 study evaluating personalized therapy in patients with Immunoglobulin A Nephropathy, current…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis [Phase 2]
Phase 2 clinical trial evaluating finerenone in patients with non-diabetic glomerulonephritis; the study is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland [Phase 2]
Phase 2 clinical trial evaluating daratumumab for monoclonal gammopathy of renal significance (MGRS) in Finland; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: TESTING -ON Post-Trial ObservatioNal Cohort Study
A post-trial observational cohort study named TESTING-ON, sponsored by The George Institute, is currently recruiting to observe outcomes in …
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study
Pediatric nephrotic syndrome study aiming to identify biomarkers and outcome predictors through genetic, transcriptomic, and secretome multi…
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis [Phase 2]
A Phase 2 clinical trial evaluating KP104 for Glomerulonephritis to assess efficacy, safety, pharmacokinetics, and pharmacodynamics; the stu…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Using Renal Elastography Measurements for Evaluation of Glomerulonephritis Patients [NA]
A clinical trial at Assiut University is exploring renal shear wave elastography to evaluate biopsy-proven glomerulonephritis patients. The …
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3 [Phase 4]
This entry notes a Phase 4 clinical trial recruiting with Huaiqihuang Granule for primary glomerulonephritis in patients with chronic kidney…
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD [Phase 3]
A Phase 3 clinical trial evaluating the efficacy of immunosuppressive therapy for IgA nephropathy in patients with stage 3 or 4 chronic kidn…
-
CLINICAL_TRIALS research · 2018-03-09Clinical Trial Update: The Canadian Glomerulonephritis Registry and Translational Research Initiative
This entry describes the Canadian Glomerulonephritis Registry and Translational Research Initiative, a clinical trial sponsored by Universit…